Janus Henderson Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,359
| Closed | -$69.3K | – | 2567 |
|
|
2023
Q3 | $69.3K | Buy |
20,359
+55
| +0.3% | +$187 | ﹤0.01% | 2543 |
|
|
2023
Q2 | $149K | Sell |
20,304
-44
| -0.2% | -$323 | ﹤0.01% | 2518 |
|
|
2023
Q1 | $211K | Sell |
20,348
-47,024
| -70% | -$487K | ﹤0.01% | 2470 |
|
|
2022
Q4 | $796K | Sell |
67,372
-77,094
| -53% | -$910K | ﹤0.01% | 1485 |
|
|
2022
Q3 | $3.03M | Buy |
144,466
+71,367
| +98% | +$1.5M | ﹤0.01% | 1145 |
|
|
2022
Q2 | $2.27M | Sell |
73,099
-720,233
| -91% | -$22.4M | ﹤0.01% | 1006 |
|
|
2022
Q1 | $32.6M | Sell |
793,332
-1,029,549
| -56% | -$42.3M | 0.02% | 622 |
|
|
2021
Q4 | $79.2M | Sell |
1,822,881
-1,047,022
| -36% | -$45.5M | 0.03% | 414 |
|
|
2021
Q3 | $144M | Sell |
2,869,903
-779,066
| -21% | -$39M | 0.06% | 289 |
|
|
2021
Q2 | $230M | Buy |
3,648,969
+889,033
| +32% | +$56M | 0.1% | 212 |
|
|
2021
Q1 | $256M | Buy |
2,759,936
+1,815,872
| +192% | +$169M | 0.12% | 191 |
|
|
2020
Q4 | $84.6M | Buy |
+944,064
| New | +$84.6M | 0.04% | 406 |
|
|
2018
Q2 | – | Sell |
-4,051
| Closed | -$213K | – | 1403 |
|
|
2018
Q1 | $213K | Buy |
+4,051
| New | +$213K | ﹤0.01% | 1337 |
|